FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.9.1  |  FHIR Version n/a  User: [n/a]

420873008: Prolonged-release suspension for injection (qualifier value)


Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
2615299012 Extended release injectable suspension (product) en Fully specified name Inactive Only initial character case insensitive SNOMED CT core module
2617961013 Extended release injectable suspension en Synonym Inactive Entire term case insensitive SNOMED CT core module
2660547014 Extended release injectable suspension (qualifier value) en Fully specified name Inactive Entire term case insensitive SNOMED CT core module
3633815017 Prolonged-release suspension for injection en Synonym Active Entire term case insensitive SNOMED CT core module
3633816016 Extended-release suspension for injection en Synonym Active Entire term case insensitive SNOMED CT core module
3633817013 Prolonged-release suspension for injection (dose form) en Fully specified name Active Entire term case insensitive SNOMED CT core module
1116651000001119 Prolonged-release suspension for injection (qualifier value) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom Edition module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Prolonged-release suspension for injection Is a Conventional release suspension for injection false Inferred relationship Existential restriction modifier
Prolonged-release suspension for injection Has dose form administration method Inject true Inferred relationship Existential restriction modifier
Prolonged-release suspension for injection Has dose form intended site Parenteral true Inferred relationship Existential restriction modifier
Prolonged-release suspension for injection Has basic dose form Suspension true Inferred relationship Existential restriction modifier
Prolonged-release suspension for injection Is a Parenteral dose form true Inferred relationship Existential restriction modifier
Prolonged-release suspension for injection Has dose form release characteristic Prolonged-release true Inferred relationship Existential restriction modifier
Prolonged-release suspension for injection Has dose form transformation No transformation true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely cabotegravir 200 milligram/1 milliliter prolonged-release suspension for injection (clinical drug) Has manufactured dose form True Prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Product containing precisely rilpivirine 300 milligram/1 milliliter prolonged-release suspension for injection (clinical drug) Has manufactured dose form True Prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Product containing precisely paliperidone (as paliperidone palmitate) 200 milligram/1 milliliter prolonged-release suspension for injection (clinical drug) Has manufactured dose form True Prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Product containing precisely estradiol cypionate 10 milligram/1 milliliter and medroxyprogesterone acetate 50 milligram/1 milliliter prolonged-release suspension for injection (clinical drug) Has manufactured dose form True Prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Paliperidone 50mg/0.5ml prolonged-release suspension for injection pre-filled syringes Has dispensed dose form True Prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Paliperidone 100mg/1ml prolonged-release suspension for injection pre-filled syringes Has dispensed dose form True Prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Paliperidone 75mg/0.75ml prolonged-release suspension for injection pre-filled syringes Has dispensed dose form True Prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Cabotegravir 600mg/3ml prolonged-release suspension for injection vials Has dispensed dose form True Prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Rilpivirine 900mg/3ml prolonged-release suspension for injection vials Has dispensed dose form True Prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Vocabria 600mg/3ml prolonged-release suspension for injection vials (ViiV Healthcare UK Ltd) 1 vial Has dispensed dose form True Prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Rekambys 900mg/3ml prolonged-release suspension for injection vials (ViiV Healthcare UK Ltd) 1 vial Has dispensed dose form True Prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Rekambys 900mg/3ml prolonged-release suspension for injection vials (ViiV Healthcare UK Ltd) Has dispensed dose form True Prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Rilpivirine 900mg/3ml prolonged-release suspension for injection vials 1 vial Has dispensed dose form True Prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Cabotegravir 600mg/3ml prolonged-release suspension for injection vials 1 vial Has dispensed dose form True Prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Vocabria 600mg/3ml prolonged-release suspension for injection vials (ViiV Healthcare UK Ltd) Has dispensed dose form True Prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Paliperidone 150mg/1.5ml prolonged-release suspension for injection pre-filled syringes Has dispensed dose form True Prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Paliperidone 700mg/3.5ml prolonged-release suspension for injection pre-filled syringes Has dispensed dose form True Prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Paliperidone 1g/5ml prolonged-release suspension for injection pre-filled syringes Has dispensed dose form True Prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Byannli 1000mg/5ml prolonged-release suspension for injection pre-filled syringes (Janssen-Cilag Ltd) 1 pre-filled disposable injection Has dispensed dose form True Prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Byannli 700mg/3.5ml prolonged-release suspension for injection pre-filled syringes (Janssen-Cilag Ltd) Has dispensed dose form True Prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Byannli 1000mg/5ml prolonged-release suspension for injection pre-filled syringes (Janssen-Cilag Ltd) Has dispensed dose form True Prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Paliperidone 1g/5ml prolonged-release suspension for injection pre-filled syringes 1 pre-filled disposable injection Has dispensed dose form True Prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Byannli 700mg/3.5ml prolonged-release suspension for injection pre-filled syringes (Janssen-Cilag Ltd) 1 pre-filled disposable injection Has dispensed dose form True Prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Paliperidone 700mg/3.5ml prolonged-release suspension for injection pre-filled syringes 1 pre-filled disposable injection Has dispensed dose form True Prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Exenatide 2mg/0.85ml prolonged-release suspension for injection pre-filled disposable devices Has dispensed dose form True Prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Bydureon BCise 2mg/0.85ml prolonged-release suspension for injection pre-filled pens (AstraZeneca UK Ltd) 4 pre-filled disposable injection Has dispensed dose form True Prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Bydureon BCise 2mg/0.85ml prolonged-release suspension for injection pre-filled pens (AstraZeneca UK Ltd) Has dispensed dose form True Prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Exenatide 2mg/0.85ml prolonged-release suspension for injection pre-filled disposable devices 4 pre-filled disposable injection Has dispensed dose form True Prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Paliperidone 75mg/0.75ml prolonged-release suspension for injection pre-filled syringes (Advanz Pharma) Has dispensed dose form True Prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Paliperidone 150mg/1.5ml prolonged-release suspension for injection pre-filled syringes (Teva UK Ltd) Has dispensed dose form True Prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Paliperidone 75mg/0.75ml prolonged-release suspension for injection pre-filled syringes 1 pre-filled disposable injection Has dispensed dose form True Prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Paliperidone 150mg/1.5ml prolonged-release suspension for injection pre-filled syringes (Advanz Pharma) 1 pre-filled disposable injection Has dispensed dose form True Prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Xeplion 150mg/1.5ml prolonged-release suspension for injection pre-filled syringes (Janssen-Cilag Ltd) 1 pre-filled disposable injection Has dispensed dose form True Prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Paliperidone 50mg/0.5ml prolonged-release suspension for injection pre-filled syringes (Advanz Pharma) 1 pre-filled disposable injection Has dispensed dose form True Prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Xeplion 50mg/0.5ml prolonged-release suspension for injection pre-filled syringes (Janssen-Cilag Ltd) Has dispensed dose form True Prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Paliperidone 150mg/1.5ml prolonged-release suspension for injection pre-filled syringes 1 pre-filled disposable injection Has dispensed dose form True Prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Paliperidone 75mg/0.75ml prolonged-release suspension for injection pre-filled syringes (Teva UK Ltd) 1 pre-filled disposable injection Has dispensed dose form True Prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Xeplion 50mg/0.5ml prolonged-release suspension for injection pre-filled syringes (Janssen-Cilag Ltd) 1 pre-filled disposable injection Has dispensed dose form True Prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Paliperidone 100mg/1ml prolonged-release suspension for injection pre-filled syringes (Advanz Pharma) Has dispensed dose form True Prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Paliperidone 150mg/1.5ml prolonged-release suspension for injection pre-filled syringes (Teva UK Ltd) 1 pre-filled disposable injection Has dispensed dose form True Prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Paliperidone 100mg/1ml prolonged-release suspension for injection pre-filled syringes (Teva UK Ltd) Has dispensed dose form True Prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Paliperidone 75mg/0.75ml prolonged-release suspension for injection pre-filled syringes (Advanz Pharma) 1 pre-filled disposable injection Has dispensed dose form True Prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Paliperidone 100mg/1ml prolonged-release suspension for injection pre-filled syringes (Teva UK Ltd) 1 pre-filled disposable injection Has dispensed dose form True Prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Paliperidone 50mg/0.5ml prolonged-release suspension for injection pre-filled syringes 1 pre-filled disposable injection Has dispensed dose form True Prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Xeplion 75mg/0.75ml prolonged-release suspension for injection pre-filled syringes (Janssen-Cilag Ltd) 1 pre-filled disposable injection Has dispensed dose form True Prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Xeplion 100mg/1ml prolonged-release suspension for injection pre-filled syringes (Janssen-Cilag Ltd) 1 pre-filled disposable injection Has dispensed dose form True Prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Xeplion 100mg/1ml prolonged-release suspension for injection pre-filled syringes (Janssen-Cilag Ltd) Has dispensed dose form True Prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Paliperidone 50mg/0.5ml prolonged-release suspension for injection pre-filled syringes (Advanz Pharma) Has dispensed dose form True Prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Paliperidone 150mg/1.5ml prolonged-release suspension for injection pre-filled syringes (Advanz Pharma) Has dispensed dose form True Prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Paliperidone 100mg/1ml prolonged-release suspension for injection pre-filled syringes (Advanz Pharma) 1 pre-filled disposable injection Has dispensed dose form True Prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Xeplion 75mg/0.75ml prolonged-release suspension for injection pre-filled syringes (Janssen-Cilag Ltd) Has dispensed dose form True Prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Paliperidone 100mg/1ml prolonged-release suspension for injection pre-filled syringes 1 pre-filled disposable injection Has dispensed dose form True Prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Xeplion 150mg/1.5ml prolonged-release suspension for injection pre-filled syringes (Janssen-Cilag Ltd) Has dispensed dose form True Prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Paliperidone 75mg/0.75ml prolonged-release suspension for injection pre-filled syringes (Teva UK Ltd) Has dispensed dose form True Prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Paliperidone 263mg/1.315ml prolonged-release suspension for injection pre-filled syringes Has dispensed dose form True Prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Paliperidone 350mg/1.75ml prolonged-release suspension for injection pre-filled syringes Has dispensed dose form True Prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Paliperidone 525mg/2.625ml prolonged-release suspension for injection pre-filled syringes Has dispensed dose form True Prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Paliperidone 175mg/0.875ml prolonged-release suspension for injection pre-filled syringes Has dispensed dose form True Prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Trevicta 175mg/0.875ml prolonged-release suspension for injection pre-filled syringes (Janssen-Cilag Ltd) Has dispensed dose form True Prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Trevicta 263mg/1.315ml prolonged-release suspension for injection pre-filled syringes (Janssen-Cilag Ltd) Has dispensed dose form True Prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Trevicta 350mg/1.75ml prolonged-release suspension for injection pre-filled syringes (Janssen-Cilag Ltd) Has dispensed dose form True Prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Trevicta 525mg/2.625ml prolonged-release suspension for injection pre-filled syringes (Janssen-Cilag Ltd) Has dispensed dose form True Prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Trevicta 175mg/0.875ml prolonged-release suspension for injection pre-filled syringes (Janssen-Cilag Ltd) 1 pre-filled disposable injection Has dispensed dose form True Prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Trevicta 263mg/1.315ml prolonged-release suspension for injection pre-filled syringes (Janssen-Cilag Ltd) 1 pre-filled disposable injection Has dispensed dose form True Prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Trevicta 350mg/1.75ml prolonged-release suspension for injection pre-filled syringes (Janssen-Cilag Ltd) 1 pre-filled disposable injection Has dispensed dose form True Prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Trevicta 525mg/2.625ml prolonged-release suspension for injection pre-filled syringes (Janssen-Cilag Ltd) 1 pre-filled disposable injection Has dispensed dose form True Prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Paliperidone 525mg/2.625ml prolonged-release suspension for injection pre-filled syringes 1 pre-filled disposable injection Has dispensed dose form True Prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Paliperidone 350mg/1.75ml prolonged-release suspension for injection pre-filled syringes 1 pre-filled disposable injection Has dispensed dose form True Prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Paliperidone 263mg/1.315ml prolonged-release suspension for injection pre-filled syringes 1 pre-filled disposable injection Has dispensed dose form True Prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Paliperidone 175mg/0.875ml prolonged-release suspension for injection pre-filled syringes 1 pre-filled disposable injection Has dispensed dose form True Prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Paliperidone 175mg/0.875ml prolonged-release suspension for injection pre-filled syringes Has manufactured dose form False Prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Paliperidone 263mg/1.315ml prolonged-release suspension for injection pre-filled syringes Has manufactured dose form False Prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Paliperidone 350mg/1.75ml prolonged-release suspension for injection pre-filled syringes Has manufactured dose form False Prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Paliperidone 525mg/2.625ml prolonged-release suspension for injection pre-filled syringes Has manufactured dose form False Prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Trevicta 525mg/2.625ml prolonged-release suspension for injection pre-filled syringes (Janssen-Cilag Ltd) Has manufactured dose form True Prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Trevicta 263mg/1.315ml prolonged-release suspension for injection pre-filled syringes (Janssen-Cilag Ltd) Has manufactured dose form True Prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Trevicta 350mg/1.75ml prolonged-release suspension for injection pre-filled syringes (Janssen-Cilag Ltd) Has manufactured dose form True Prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Trevicta 175mg/0.875ml prolonged-release suspension for injection pre-filled syringes (Janssen-Cilag Ltd) Has manufactured dose form True Prolonged-release suspension for injection Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start